Table 1: Total Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in 7MM
Table 2: Total Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in United States
Table 4: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in United States*
Table 5: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in United States*
Table 6: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in United States
Table 7: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in United States
Table 8: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in Germany
Table 9: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Germany*
Table 10: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Germany*
Table 11: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in Germany
Table 12: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in Germany
Table 13: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in France
Table 14: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in France*
Table 15: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in France*
Table 16: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in France
Table 17: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in France
Table 18: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in Italy
Table 19: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Italy*
Table 20: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Italy*
Table 21: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in Italy
Table 22: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in Italy
Table 23: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in Spain
Table 24: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Spain*
Table 25: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Spain*
Table 26: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in Spain
Table 27: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in Spain
Table 28: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in UK
Table 29: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in UK*
Table 30: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in UK*
Table 31: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in UK
Table 32: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in UK
Table 33: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in Japan
Table 34: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Japan*
Table 35: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Japan*
Table 36: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in Japan
Table 37: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in Japan
Table 38: Marketed Drugs
Table 39: Pipeline Drugs
Table 40:7MM- Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Table 41:7MM- Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 42:7MM- Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 43: United States-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Table 44: United States-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 45: United States-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 46: Germany-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Table 47: Germany-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 48: Germany-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 49: France-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Table 50: France-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 51: France-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 52: Italy-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Table 53: Italy-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 54: Italy-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 55: Spain-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Table 56: Spain-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 57: Spain-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 58: UK-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Table 59: UK-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 60: UK-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 61: Japan-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Table 62: Japan-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Table 63: Japan-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
*Indication Specific
LIST OF FIGURE
Figure 1: Total Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in United States
Figure 4: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in United States*
Figure 5: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in United States*
Figure 6: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in United States
Figure 7: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in United States
Figure 8: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in Germany
Figure 9: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Germany*
Figure 10: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Germany*
Figure 11: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in Germany
Figure 12: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in Germany
Figure 13: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in France
Figure 14: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in France*
Figure 15: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in France*
Figure 16: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in France
Figure 17: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in France
Figure 18: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in Italy
Figure 19: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Italy*
Figure 20: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Italy*
Figure 21: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in Italy
Figure 22: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in Italy
Figure 23: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in Spain
Figure 24: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Spain*
Figure 25: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Spain*
Figure 26: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in Spain
Figure 27: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in Spain
Figure 28: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in UK
Figure 29: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in UK*
Figure 30: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in UK*
Figure 31: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in UK
Figure 32: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in UK
Figure 33: Prevalent/Incident Cases of the Non-Small Cell Lung Cancer (NSCLC) in Japan
Figure 34: Sub-Type Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Japan*
Figure 35: Sex- Specific Cases of the Non-Small Cell Lung Cancer (NSCLC) in Japan*
Figure 36: Diagnosed Cases of the Non-Small Cell Lung Cancer (NSCLC) in Japan
Figure 37: Treated Cases of the Non-Small Cell Lung Cancer (NSCLC) in Japan
Figure 38: Marketed Drugs
Figure 39: Emerging Drugs
Figure 40:7MM- Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Figure 41:7MM- Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 42:7MM- Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 43: United States-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Figure 44: United States-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 45: United States-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 46: Germany-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Figure 47: Germany-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 48: Germany-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 49: France-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Figure 50: France-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 51: France-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 52: Italy-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Figure 53: Italy-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 54: Italy-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 55: Spain-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Figure 56: Spain-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 57: Spain-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 58: UK-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Figure 59: UK-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 60: UK-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 61: Japan-Market Size of Non-Small Cell Lung Cancer (NSCLC) in USD MM
Figure 62: Japan-Market Share Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
Figure 63: Japan-Market Sales of Non-Small Cell Lung Cancer (NSCLC) by Therapies in USD MM
*Indication Specific